Recurrent calcium nephrolithiasis associated with primary aldosteronism.

Hyperaldosteronism is known to cause salt retention, hypokalemia, and metabolic alkalosis. Prior research has shown that these electrolyte imbalances can affect kidney function. However, the link between hyperaldosteronism and hypocitraturia remains underexplored. No prior work had resolved how aldosterone influences citrate excretion. This gap motivated further investigation into the role of aldosterone in urinary citrate levels. That uncertainty drove the need to examine how this hormone might contribute to kidney stone formation. It was already known that hypercalciuria is a risk factor for calcium stones. But the interplay between aldosterone, citrate, and calcium excretion had not been clearly established.

This case report aims to highlight a rare but significant consequence of primary hyperaldosteronism. The specific problem is the association between aldosterone excess and hypocitraturia. The motivation comes from the patient’s severe and recurrent calcium nephrolithiasis. The authors sought to investigate whether this condition could be corrected by addressing the underlying hormonal imbalance. The study focuses on a patient with an adrenal adenoma causing hyperaldosteronism. The goal was to determine if surgical removal of the tumor would resolve the urinary abnormalities. The authors also aimed to review the physiological mechanisms behind aldosterone’s effects on citrate and calcium handling. This case may suggest a broader clinical implication for similar patients.

The study involved a single patient with a confirmed diagnosis of primary hyperaldosteronism due to an adrenal adenoma. Urinary and serum electrolytes were measured to assess citrate and calcium levels. The patient’s clinical history included multiple episodes of renal calcium stones. The authors reviewed the patient’s pre- and post-surgical data. Adrenalectomy was performed to remove the aldosterone-producing tumor. Post-operative follow-up included repeat measurements of urinary citrate and calcium excretion. The clinical course was monitored to determine if stone recurrence decreased. The findings were contextualized within the broader literature on aldosterone’s effects on kidney function.

The patient exhibited severe hypocitraturia and hypercalciuria before surgery. These abnormalities were consistent with aldosterone-induced changes in renal handling of citrate and calcium. After adrenalectomy, the patient’s urinary citrate levels normalized. Hypercalciuria also improved significantly following the procedure. The patient experienced a marked reduction in recurrent calcium stone episodes. These results suggest a direct link between aldosterone excess and nephrolithiasis. The correction of hormonal imbalance led to physiological and clinical improvement. The case supports the hypothesis that aldosterone contributes to hypocitraturia and stone formation.

The authors propose that primary hyperaldosteronism can lead to hypocitraturia and calcium nephrolithiasis. This case demonstrates that correcting the hormonal imbalance may resolve the urinary abnormalities. The findings suggest a possible causal relationship between aldosterone and stone formation. The authors emphasize the need for further investigation into this under-recognized consequence. The data support the idea that aldosterone influences citrate excretion in the kidney. The clinical response to adrenalectomy indicates a reversible effect of the hormonal imbalance. The study does not claim that all cases of calcium stones are due to hyperaldosteronism. The authors conclude that this condition should be considered in patients with unexplained hypocitraturia and recurrent stones.